Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Bcl-2 Family
    (146)
  • Apoptosis
    (63)
  • Caspase
    (51)
  • Autophagy
    (19)
  • NF-κB
    (17)
  • ERK
    (16)
  • PARP
    (15)
  • Akt
    (12)
  • TNF
    (11)
  • Others
    (94)
Filter
Search Result
Results for "

bcl-2

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    344
    TargetMol | Inhibitors_Agonists
  • Compound Libraries
    1
    TargetMol | Compound_Libraries
  • Peptide Products
    14
    TargetMol | Peptide_Products
  • PROTAC Products
    13
    TargetMol | PROTAC
  • Natural Products
    127
    TargetMol | Natural_Products
  • Recombinant Protein
    24
    TargetMol | Recombinant_Protein
  • Isotope Products
    2
    TargetMol | Isotope_Products
  • Antibody Products
    17
    TargetMol | Antibody_Products
  • Disease Modeling
    1
    TargetMol | Disease_Modeling_Products
ABT-737
T2099852808-04-9
ABT-737 is a BH3 mimetic and an inhibitor of Bcl-2, Bcl-xL, and Bcl-w (EC50=30.3 nM 78.7 nM 197.8 nM). ABT-737 exhibits antitumor activity and anti-aging activity.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Navitoclax
ABT-263
T2101923564-51-6
Navitoclax (ABT-263) is a potent oral Bcl-2 inhibitor that binds to Bcl-xL, Bcl-2, and Bcl-w proteins (Ki<1 nM), demonstrating antitumor activity and inducing apoptosis.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Venetoclax
GDC-0199, ABT-199, ABT199, ABT 199
T21191257044-40-8
Venetoclax (ABT-199) is a Bcl-2 inhibitor (Ki<0.01 nM) with potent, selective, and orally active properties. Venetoclax has a 3-order-of-magnitude lower affinity for Bcl-xL and Bcl-W (Kis=48 245 nM). Venetoclax induces autophagy and apoptosis.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Docetaxel trihydrate
RP-56976 (Trihydrate), RP56976 (NSC 628503) Trihydrate
T0186148408-66-6
Docetaxel trihydrate (RP-56976 Trihydrate) is an antineoplastic agent that has a unique mechanism of action as an inhibitor of cellular mitosis and that currently plays a central role in the therapy of many solid tumor including breast and lung cancer. Therapy with docetaxel has been associated with a low rate of serum enzyme elevations and rarely to instances of acute hepatic necrosis generally due to severe hypersensitivity reactions or sepsis.
  • Inquiry Price
4-6 weeks
Size
QTY
Thymoquinone
Thymoquinon, NSC 2228
T4088490-91-5
Thymoquinone (NSC 2228) is a compound be found in herbs and spices with anti-inflammatory and anti-oxidant effects.
  • Inquiry Price
Size
QTY
A-1155463
A1155463, A 1155463
T67481235034-55-5
A-1155463, a highly potent and selective BCL-XL inhibitor, shows picomolar binding affinity to BCL-XL, and >1000-fold weaker binding to BCL-2 and related proteins BCL-W(Ki=19 nM) and MCL-1(Ki>440 nM).
  • Inquiry Price
Size
QTY
TargetMol | Citations Cited
Ergosta-4,6,8(14),22-tetraen-3-one
TN161719254-69-4
Ergosta-4,6,8(14),22-tetraen-3-one exhibits cytotoxic activity against human gastric cancer cells and can induce G2 M cell cycle arrest and apoptosis in human hepatocellular carcinoma (HepG2) cells. These findings could facilitate the further use of various medicinal fungi in cancer treatment.
  • Inquiry Price
Size
QTY
Zibotentan
ZD4054
T6258186497-07-4
Zibotentan (ZD4054) (ZD4054) is a specific Endothelin (ET)A antagonist with IC50 of 21 nM, exhibiting no activity at ETB. Phase 3.
  • Inquiry Price
4-6 weeks
Size
QTY
s55746
BLC201
T12824L1448584-12-0
S55746 (BLC201) is an effective and selective BCL-2 inhibitor (Ki: 1.3 nM and a Kd of 3.9 nM).
  • Inquiry Price
Size
QTY
Medicarpin
TN191832383-76-9
N-Methylnicotinamide is one of the endogenous metabolites that ameliorates endothelial dysfunction.
  • Inquiry Price
Size
QTY
obatoclax mesylate
Obatoclax, GX15-070
T6275803712-79-0
Obatoclax Mesylate (GX15-070) is a Bcl-2 antagonist (Ki: 0.22 μM) and can induce apoptosis with up-regulation of Bim, induced cytochrome c release, and activation of caspase-3.
  • Inquiry Price
Size
QTY
(S)-Gossypol (acetic acid)
(S)-Gossypol acetic acid, (S)-(+)-Gossypol acetic acid
T139801189561-66-7
(S)-Gossypol acetic acid is the isomer of a natural product Gossypol.
  • Inquiry Price
7-10 days
Size
QTY
17-Hydroxy sprengerinin C
TN11951029017-75-1
17-Hydroxy sprengerinin C is a glycoside compound isolated from rhizomes of Polygonatum sibiricum with stronger anticancer activities. 17-Hydroxy sprengerinin C reduces the expression of Blc-2 and pro-caspase3 and increases the production of Bax.
  • Inquiry Price
7-10 days
Size
QTY
TargetMol | Inhibitor Sale
ginsenoside rg6
TN1094147419-93-0
Ginsenoside Rg6 can inhibit JK cell proliferation in human lymphocytoma and induce its apoptosis, the mechanism may through mitochondrial dysfunction and an increase of Bax expression and decrease of Bcl-2 expression.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Crenulatin
TN153263026-02-8
Crenulatin has dual- direction effects on apoptosis of cerebral microvascular endothelial cells, inhibitive effect in 25 mg L and stimulative effect in 100 mg L group, respectively; the mechanism is related to the alterations of Fas Bcl-2 expression and caspase-3 activity.
  • Inquiry Price
Size
QTY
TV 3279
T77332209394-29-6In house
TV 3279 is a novel ChE-MAI inhibitor , and the neuroprotective properties depend on their ability to induce the anti-apoptotic proteins PKC, Bcl-2, Bcl-x, and SOD, and to block the nuclear translocation of the pro-apoptotic enzyme glyceraldehyde phosphate dehydrogenase in PC-12 and neuroblastoma cells.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Erianin
T386495041-90-0
Erianin is a nature product extracted from Dendrobium chrysotoxum, has notable antitumour activity , can cause extensive tumour necrosis, growth delay. Erianin has antiangiogenic action by inhibiting endothelial metabolism in a JNK SAPK-dependent manner a
  • Inquiry Price
Size
QTY
TargetMol | Citations Cited
MCL-1/BCL-2-IN-4
T119712163793-56-2
MCL-1 BCL-2-IN-4 is a selective and potent dual inhibitor of Mcl-1 and Bcl-2.
  • Inquiry Price
6-8 weeks
Size
QTY
Bcl-2-IN-21
T89910
Bcl-2-IN-21 (compound C1), an iridium-based anticancer agent, effectively targets and inhibits Bcl-2, thereby impeding cancer cell colony formation and promoting increased levels of Bax and caspase 3.
  • Inquiry Price
Size
QTY
Bcl-2-IN-16
T829102858632-01-4
Bcl-2-IN-16 is an inhibitor of Bcl-2 (B-cell lymphoma 2) [1].
  • Inquiry Price
8-10 weeks
Size
QTY
bcl-2-in-9
T637572490542-33-9
Bcl-2-IN-9 is a novel, pro-apoptotic, low cytotoxic Bcl-2 inhibitor (IC50: 2.9 μM) that downregulates Bcl-2 expression, induces apoptosis in cancer cells, and exhibits high selectivity for leukemia cells.
  • Inquiry Price
6-8 weeks
Size
QTY
Sulforaphene
TL0016592-95-0
Sulforaphene is a natural product isolated from radish seeds, exhibits an ED50 against velvetleaf seedlings approximately 2 x 10 -4 M. Sulforaphene promotes cancer cells apoptosis and inhibits migration via inhibiting EGFR, p-ERK1 2, NF‐κB and other signa
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Bcl-2/Mcl-1-IN-4
T89042
Bcl-2 Mcl-1-IN-4 (compound 20) acts as a dual inhibitor targeting Bcl-2 (Ki=0.49 μM) and Mcl-1 (Ki=0.51 μM). This compound effectively suppresses cancer cell proliferation and induces apoptosis in U937 cells. It is utilized in cancer research.
  • Inquiry Price
Size
QTY
bcl-2-in-4
T742972703134-40-9
Bcl-2-IN-4, an orally active and selective inhibitor of Bcl-2, demonstrates potent efficacy with an IC50 value of 1.5 nM and exhibits more than 200-fold selectivity over Bcl-xL (IC50 of 411 nM). Additionally, it effectively inhibits the proliferation of RS4;11 cells, achieving an IC50 of 2.7 nM.
  • Inquiry Price
Size
QTY